Lina Palaiodimou
Overview
Explore the profile of Lina Palaiodimou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsivgoulis G, Katsanos A, Romoli M, Sarraj A, Krogias C, Karapanayiotides T, et al.
J Neurol Neurosurg Psychiatry
. 2025 Mar;
PMID: 40089306
Background: Current international guidelines suggest andexanet alfa (AA) for the management of factor Xa inhibitor-associated intracranial haemorrhage (ICH). However, those recommendations are based on low-quality evidence and there is uncertainty...
2.
Stefanou M, Panagiotopoulos E, Palaiodimou L, Theodorou A, Magoufis G, Spiliopoulos S, et al.
Eur Stroke J
. 2025 Mar;
:23969873251324863.
PMID: 40079576
Introduction: Evidence on endovascular therapy (EVT) for symptomatic intracranial stenosis (sICAS) from randomized-controlled clinical trials (RCTs) is conflicting. While prior RCTs on percutaneous transluminal angioplasty and stenting (PTAS) demonstrated harm...
3.
Palaiodimou L, Tsivgoulis G
JAMA Netw Open
. 2025 Mar;
8(3):e250555.
PMID: 40072440
No abstract available.
4.
Romoli M, Urbinati G, Tudisco V, Toscano A, Eusebi P, Giammello F, et al.
Neurology
. 2025 Feb;
104(6):e213426.
PMID: 39999395
Background And Objectives: The risk of recurrent ischemic stroke, intracranial hemorrhage, and mortality in people with atrial fibrillation detected after stroke (AFDAS) is still unclear compared with people with known...
5.
Stefanou M, Panagiotopoulos E, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, et al.
EXCLI J
. 2025 Jan;
23():1463-1486.
PMID: 39850323
Since the outbreak of the COVID-19 pandemic, there has been a global surge in patients presenting with prolonged or late-onset debilitating sequelae of SARS-CoV-2 infection, colloquially termed long COVID. This...
6.
Sterpi A, Triantafyllou A, Tzanetakos D, Ampantzi E, Kitsos D, Theodorou A, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768480
Radiotherapy (RT) remains crucial in treating both primary and metastatic central nervous system cancer. Despite advancements in modern techniques that mitigate some toxic adverse effects, magnetic resonance imaging (MRI) scans...
7.
Korakas E, Thymis J, Oikonomou E, Mourouzis K, Kountouri A, Pliouta L, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768420
: The association between diabetic nephropathy and arterial elasticity and endothelial function is well established. In this study, we compared the effect of the combination of dulaglutide and dapagliflozin versus...
8.
Bakola E, Palaiodimou L, Kargiotis O, Safouris A, Psychogios K, Karapanayiotides T, et al.
Eur J Neurol
. 2024 Dec;
32(1):e16584.
PMID: 39706201
Background: Microembolic signals (MES) can be detected using transcranial Doppler (TCD) ultrasound in several clinical scenarios, including acute ischemic stroke (AIS). This narrative review aims to provide insights into their...
9.
Palaiodimou L, Tsivgoulis G
Med
. 2024 Nov;
5(11):1342-1344.
PMID: 39520978
The OCEANIC-AF trial was terminated early due to inferiority of asundexian compared with apixaban for the prevention of stroke and systemic embolism in patients with atrial fibrillation. However, the promisingly...
10.
Tentolouris A, Stefanou M, Vrettou A, Palaiodimou L, Moschovos C, Papadopoulou M, et al.
J Diabetes Complications
. 2024 Oct;
38(12):108883.
PMID: 39461229
Background And Aims: Autoimmune nodopathies comprise a newly-established subtype of immune-mediated peripheral neuropathies, characterized by circulating autoantibodies that target nodal-paranodal proteins, including contactin-1 (CNTN1), contactin-associated protein-1 (Caspr1), neurofascin-155 (NF155) and...